Navigation Links
Sanofi-aventis Oncology Data to be Presented at San Antonio Breast Cancer Symposium
Date:12/9/2010

ung Cancer:

  • TAXOTERE as a single agent is indicated for the treatment of patients with locally advanced or metastatic non-small cell lung cancer after failure of prior platinum-based chemotherapy
  • TAXOTERE in combination with cisplatin is indicated for the treatment of patients with unresectable, locally advanced or metastatic non-small cell lung cancer who have not previously received treatment

  • Prostate Cancer:

  • TAXOTERE in combination with prednisone is indicated for the treatment of patients with androgen independent (hormone refractory) metastatic prostate cancer

  • Gastric Adenocarcinoma:

  • TAXOTERE in combination with cisplatin and fluorouracil is indicated for the treatment of patients with advanced gastric adenocarcinoma, including adenocarcinoma of the gastroesophageal junction, who have not received prior treatment

  • Head and Neck Cancer:  

  • TAXOTERE in combination with cisplatin and fluorouracil is indicated for the induction treatment of patients with locally advanced squamous cell carcinoma of the head and neck (SCCHN)

  • Important Safety Information for Taxotere® (docetaxel) Injection ConcentrateWARNING

  • The incidence of treatment-related mortality associated with Taxotere® therapy is increased in patients with abnormal liver function, in patients receiving higher doses, and in patients with non-small cell lung carcinoma and a history of prior treatment with platinum-based chemotherapy who receive Taxotere® as a single agent at a dose of 100 mg/m2

  • Taxotere® should not be given to patients with bilirubin > upper limit of normal (ULN), or to patients with AST and/or ALT > 1.5 X ULN concomitant with alkaline phosphatase > 2.5 X ULN  
  • Patients with elevations of bilirubin or abnormalities of transaminase concurrent with alkaline phosphatase are at increased risk for the development of gra
    '/>"/>

  • SOURCE sanofi-aventis
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8

    Related medicine technology :

    1. Sanofi-aventis Sends Letter to Genzyme Seeking Clarification on Potential Board Actions
    2. Covance and sanofi-aventis Finalize Agreements for 10-year Strategic R&D Alliance
    3. Sanofi-aventis to Acquire BMP Sunstone Creating a Strong Consumer Healthcare Platform in China
    4. Sanofi-aventis Initiates Phase III Study with Teriflunomide as Adjunct Therapy with Interferon Beta to Further Explore Clinical Benefits in Multiple Sclerosis
    5. Sanofi-aventis Commences Tender Offer to Acquire All Outstanding Shares of Genzyme for $69 per Share in Cash
    6. Covance and Sanofi-Aventis Sign Definitive Agreements for 10-Year Strategic R&D Alliance
    7. European Hospital Anticoagulant Market Dominated by Sanofi-Aventiss Clexane
    8. Reportlinker Adds Sanofi-Aventis: PharmaVitae Profile
    9. Sanofi-aventis Announces Non-Binding Offer to Acquire Genzyme
    10. Sanofi-Aventis and Novalar File Marketing Authorization Application for OraVerse® in Five Key European Countries
    11. Oramed Pharmaceuticals and sanofi-aventis Enter Into an Agreement for the Insulin Supply of Orameds Oral Insulin Capsules
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:7/2/2015)... SHENZHEN , Chine, 3 juillet 2015 ... séquençage à haut débit de l,ADN situé à ... la certification de  l,American College of Pathologists  (Collège ... BGI à Hong Kong ... nouvelle génération à recevoir la certification du CAP ...
    (Date:7/2/2015)... FORT LAUDERDALE, Fla. , July 2, 2015 ... & Co., is pleased to announce that its ... Inc. ("Insight Beverages") to Kerry Group plc (ISE: ... focused on taste and nutrition systems, as well ... food, beverage and pharmaceutical markets. Farlie Turner served ...
    (Date:7/2/2015)... , June 26, 2015 Research ... "Vitamin D Market by Analog, Application, End-User & by ... to their offering. This market is projected to ... vitamin D in different applications and rising opportunities in countries ... , Italy , and ...
    Breaking Medicine Technology:BGI obtient la certification du Collège des pathologistes américains (CAP) 2Farlie Turner's Consumer Group Completes Sale of Insight Beverages to Kerry 2Vitamin D Market by Analog, Application, End-User & by Region - Global Trends & Forecast to 2020: Increasing Recommendation By Doctors & Associations 2Vitamin D Market by Analog, Application, End-User & by Region - Global Trends & Forecast to 2020: Increasing Recommendation By Doctors & Associations 3
    ... Reportlinker.com announces that a new market ... The Global Pharmaceutical Fine ... http://www.reportlinker.com/p0535967/The-Global-Pharmaceutical-Fine-Chemicals-Market-Outlook-to-2015.html?utm_source=prnewswire&utm_medium=pr&utm_campaign=Chemical_and_Material ... a comprehensive overview of the global pharmaceutical ...
    ... 2011 In the press release, "Lilly Presents Data ... 2011, by Eli Lilly and Company (NYSE: LLY ... overall responses were as follows:  one partial response in the ... disease of 41 percent (n=9) in leiomyosarcoma; 35 percent (n=6) ...
    Cached Medicine Technology:Reportlinker Adds The Global Pharmaceutical Fine Chemicals Market Outlook to 2015 2Reportlinker Adds The Global Pharmaceutical Fine Chemicals Market Outlook to 2015 3Reportlinker Adds The Global Pharmaceutical Fine Chemicals Market Outlook to 2015 4Reportlinker Adds The Global Pharmaceutical Fine Chemicals Market Outlook to 2015 5Reportlinker Adds The Global Pharmaceutical Fine Chemicals Market Outlook to 2015 6Correction: Lilly Presents Data on Cixutumumab in Five Subtypes of Sarcomas 2Correction: Lilly Presents Data on Cixutumumab in Five Subtypes of Sarcomas 3Correction: Lilly Presents Data on Cixutumumab in Five Subtypes of Sarcomas 4Correction: Lilly Presents Data on Cixutumumab in Five Subtypes of Sarcomas 5Correction: Lilly Presents Data on Cixutumumab in Five Subtypes of Sarcomas 6
    (Date:7/5/2015)... ... July 05, 2015 , ... Doctors at the Swedish Cancer Institute in ... one day change the outlook for people with pleural mesothelioma. Surviving Mesothelioma has just ... Researchers report that five mesothelioma patients treated with 25Gy of radiation over five days ...
    (Date:7/4/2015)... ... 2015 , ... When a hacker gains access to someone’s email account, it can lead to ... July 1st, the FTC issued a scam alert about a social engineering scam ... a password reset instigated by the hacker. All they have to do is click ...
    (Date:7/3/2015)... ... , ... On June 30th SEO authority and veteran Internet ... "Page One Engine" . The program, which has been hailed as the ... well-known marketers. HonestyFirstReviews.com's Tiffany Hendricks has joined the party, publishing an in-depth review ...
    (Date:7/3/2015)... ... July 03, 2015 , ... B. ... has been retained to lead a national president recruitment for Regional ... the healthcare industry, B. E. Smith has recently placed more than 1,000 healthcare ...
    (Date:7/3/2015)... Louis, MO (PRWEB) , ... July 03, 2015 , ... ... responsive website to replace their existing Talcum Powder Cancer Lawsuit Center website. Just as ... talcum powder lawsuit news , offering timely lawsuit updates and ovarian cancer warning ...
    Breaking Medicine News(10 mins):Health News:New Mesothelioma Study Calls IMRT/Surgery Combo “Innovative and Promising”, According to Surviving Mesothelioma 2Health News:New FTC Scam Alert Shows Latest Example of Social Engineering Dangers 2Health News:New FTC Scam Alert Shows Latest Example of Social Engineering Dangers 3Health News:New FTC Scam Alert Shows Latest Example of Social Engineering Dangers 4Health News:Page One Engine - Review Of Dori Friend's SEO Training Course Released 2Health News:Regional Care, Inc. Retains B. E. Smith to Recruit New President 2Health News:Regional Care, Inc. Retains B. E. Smith to Recruit New President 3Health News:Talcum Powder Lawsuit News: Cancer Attorneys Launch Updated Mobile Site 2Health News:Talcum Powder Lawsuit News: Cancer Attorneys Launch Updated Mobile Site 3
    ... CMS Training Program,To Address Federal Regulator’s New Marketing Compliance Guidelines ... ... 8, 2008 -- Connextions Inc. announced today that ... intensive training program for its in-house licensed insurance agents in ...
    ... Growing Number of Measures Helping Those Suffering,from Mental Illness, ... making it,easier for someone with a severe mental illness ... Governor Bobby Jindal on,June 21, 2008. The law, which ... year, will take effect on August 15., "Nicola,s ...
    ... Need for Parents to Include Life Insurance ... in Their College-Funding Plans, ARLINGTON, ... -- turns. When a loved one dies, it can be particularly,painful. ... that comes when the head of the household dies,prematurely with little ...
    ... people suffer from preventable, treatable diseases around,the world, ... Global Health Progress, TOYAKO, Japan, July 8 ... Health Organization (WHO) and,the Drugs for Neglected Diseases ... the importance of neglected diseases as a global ...
    ... An economist examining the,proposed merger of Highmark, Inc. ... companies would have a market share far greater,than ... presented to the,Pennsylvania Insurance Department today in Pittsburgh ... International, the proposed merger,would result in a combined ...
    ... the most complex and challenging mental disorder in the ... and longterm treatment needs and may be associated in ... burden for both the individual and family. It is ... clinically severe mood disorder. The disorder is called bipolar, ...
    Cached Medicine News:Health News:Connextions Inc. Works to Ensure CMS Compliance for Medicare Advantage Plan Providers 2Health News:Connextions Inc. Works to Ensure CMS Compliance for Medicare Advantage Plan Providers 3Health News:Louisiana Improves Law for Treating Mentally Ill 2Health News:LIFE Foundation Asks Public to Vote to Determine its $5,000 Life Lessons College Scholarship Winner 2Health News:LIFE Foundation Asks Public to Vote to Determine its $5,000 Life Lessons College Scholarship Winner 3Health News:Global Health Progress Joins WHO and DNDi to Call For Increased Commitments to Fighting Neglected Tropical Diseases 2Health News:Economist Finds Highmark/IBC Merger Would Result in 70 Percent Share in Pennsylvania, Far Higher Than Initial Reports 2Health News:The ECNP consensus statement on bipolar depression 2
    Tube for Right Bronchus - Ruschelit™ PVC. Color coded for easy identification of ports, balloons and 15mm connectors. High volume/low pressure cuffs. With Carina hook. X-ray opaque line. Gradua...
    ... For Laryngotracheal Instillation of Topical ... adult populations, this cuffed tube incorporates ... for spray application of topical anesthetic ... ,SHERIDAN offers three endotracheal tubes designs ...
    SPIRAL-FLEX® Reinforced Oral/Nasal Uncuffed Endotracheal Tubes...
    ... ,Designed for neonatal and pediatric ... incorporates a monitoring lumen within the ... to the distal tip. Luer lock ... convenient connection for CO2 monitoring, pressure ...
    Medicine Products: